BACKGROUND: BCR-ABL tyrosine kinase inhibitors (TKIs) have been increasingly linked to pulmonary arterial hypertension (PAH) since 2009, although supporting evidence is limited. Our objective was to ...
Radical health system wide change is needed for the new cancer plan to succeed where others have failed, write Bernard Rachet ...